{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:34:35Z","timestamp":1782772475968,"version":"3.54.5"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9,15]]},"DOI":"10.2146\/ajhp150781","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T10:08:59Z","timestamp":1473242939000},"page":"1442-1450","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacist prescribing practices in a clinical pharmacy cardiac risk service"],"prefix":"10.1093","volume":"73","author":[{"given":"Brittany A.","family":"Todd","sequence":"first","affiliation":[{"name":"Kaiser Permanente Colorado, Aurora, CO and University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Donald G.","family":"Lamprecht","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Colorado, Aurora, CO and University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila L.","family":"Stadler","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Colorado, Aurora, CO and University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041103020531300_b1-0731442","unstructured":"Levy J . In U.S., uninsured rate dips to 11.9% in first quarter (April13, 2015). www.gallup.com\/poll\/182348\/uninsured-rate-dips-first-quarter.aspx (accessed 2015 Sep 9)."},{"key":"key\n\t\t\t\t2019041103020531300_b2-0731442","unstructured":"Avalere Health LLC. Exploring pharmacists\u2019 role in a changing healthcare environment (May2014). http:\/\/assets.fiercemarkets.net\/public\/Pharmacist%20Report.pdf (accessed 2016 Jan 27)."},{"key":"key\n\t\t\t\t2019041103020531300_b3-0731442","article-title":"AMA does not want pharmacists to prescribe medication","author":"Pullen"},{"key":"key\n\t\t\t\t2019041103020531300_b4-0731442","doi-asserted-by":"crossref","first-page":"36A","DOI":"10.1016\/S0002-9149(99)00937-6","article-title":"Optimizing treatment of dyslipidemia in patients with coronary artery disease in the managed-care environment (the Rocky Mountain Kaiser Permanente experience)","volume":"85","author":"Merenich","year":"2000","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019041103020531300_b5-0731442","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0002-9149(99)00117-4","article-title":"Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease","volume":"83","author":"Sueta","year":"1999","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019041103020531300_b6-0731442","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2146\/ajhp060022","article-title":"Clinical pharmacy cardiac risk service for managing patients with coronary artery disease in a health maintenance organization","volume":"64","author":"Sandhoff","year":"2007","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019041103020531300_b7-0731442","unstructured":"Senate Bill 15-192. Section 1. Colorado revised statutes, 12-42.5-102. www.leg.state.co.us\/clics\/clics2015a\/csl.nsf\/fsbillcont2\/5C1A5B10580C113687257DDA007EA9E6\/$FILE\/192_enr.pdf (accessed 2015 Sep 15)."},{"key":"key\n\t\t\t\t2019041103020531300_b8-0731442","unstructured":"Department of Regulatory Agencies. State board of pharmacy rules 3 CCR 719-1. Proposed rule amendments. Rule 6.00.30 (September14, 2015). www.colorado.gov\/pacific\/dora\/Pharmacy_Laws#Rules (accessed 2016 Feb 25)."},{"key":"key\n\t\t\t\t2019041103020531300_b9-0731442","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. A report to the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041103020531300_b10-0731442","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacl.2015.09.002","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1\u2014full report","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol"},{"key":"key\n\t\t\t\t2019041103020531300_b11-0731442","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jch.12237","article-title":"Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension","volume":"16","author":"Weber","year":"2014","journal-title":"J Clin Hypertens"},{"key":"key\n\t\t\t\t2019041103020531300_b12-0731442","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041103020531300_b13-0731442","first-page":"S4","volume":"38","author":"Standards of medical care in diabetes\u20142015: summary of revisions","year":"2015","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041103020531300_b14-0731442","doi-asserted-by":"crossref","first-page":"403","DOI":"10.18553\/jmcp.2005.11.5.403","article-title":"Telephone and mail interventions provided by a clinical pharmacy cardiac risk reduction service","volume":"11","author":"Holsclaw","year":"2005","journal-title":"J Manag Care Pharm"},{"issue":"3","key":"key\n\t\t\t\t2019041103020531300_b15-0731442","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7812\/TPP\/08-007","article-title":"Collaborative cardiac care service: a multidisciplinary approach to caring for patients with coronary artery disease","volume":"12","author":"Sandhoff","year":"2008","journal-title":"Perm J"},{"key":"key\n\t\t\t\t2019041103020531300_b16-0731442","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1592\/phco.27.10.1370","article-title":"Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease","volume":"27","author":"Merenich","year":"2007","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t2019041103020531300_b17-0731442","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1592\/phco.30.11.1127","article-title":"Reduced healthcare expenditures after enrollment in a collaborative cardiac care service","volume":"30","author":"Delate","year":"2010","journal-title":"Pharmacotherapy"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/73\/18\/1442\/28335092\/ajhp1442.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T21:28:49Z","timestamp":1657229329000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/73\/18\/1442\/5101624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,15]]},"references-count":17,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2016,9,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp150781","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,9,15]]},"published":{"date-parts":[[2016,9,15]]}}}